BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1777423)

  • 1. Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation.
    Wiels J; Mangeney M; Tétaud C; Tursz T
    Int Immunol; 1991 Dec; 3(12):1289-300. PubMed ID: 1777423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.
    Taga S; Tétaud C; Mangeney M; Tursz T; Wiels J
    Biochim Biophys Acta; 1995 Jan; 1254(1):56-65. PubMed ID: 7811747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines.
    Taga S; Mangeney M; Tursz T; Wiels J
    Int J Cancer; 1995 Apr; 61(2):261-7. PubMed ID: 7705957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells.
    Schwartz-Albiez R; Dörken B; Möller P; Brodin NT; Monner DA; Kniep B
    Int Immunol; 1990; 2(10):929-36. PubMed ID: 2078521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subpopulations of B cells in germinal centers. III. HJ6, a monoclonal antibody, binds globoside and a subpopulation of germinal center B cells.
    Madassery JV; Gillard B; Marcus DM; Nahm MH
    J Immunol; 1991 Aug; 147(3):823-9. PubMed ID: 1713606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells.
    Fenderson BA; Andrews PW; Nudelman E; Clausen H; Hakomori S
    Dev Biol; 1987 Jul; 122(1):21-34. PubMed ID: 3297853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.
    Miyamoto D; Ueno T; Takashima S; Ohta K; Miyawaki T; Suzuki T; Suzuki Y
    Glycoconj J; 1997 Apr; 14(3):379-88. PubMed ID: 9147061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globo-series carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells.
    Krupnick JG; Damjanov I; Damjanov A; Zhu ZM; Fenderson BA
    Int J Cancer; 1994 Dec; 59(5):692-8. PubMed ID: 7960243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells.
    Wenk J; Andrews PW; Casper J; Hata J; Pera MF; von Keitz A; Damjanov I; Fenderson BA
    Int J Cancer; 1994 Jul; 58(1):108-15. PubMed ID: 8014006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD77: an antigen of germinal center B cells entering apoptosis.
    Mangeney M; Richard Y; Coulaud D; Tursz T; Wiels J
    Eur J Immunol; 1991 May; 21(5):1131-40. PubMed ID: 1709864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.
    Sawada R; Hotta H; Chung YS; Sowa M; Tai T; Yano I
    Jpn J Cancer Res; 1998 Feb; 89(2):167-76. PubMed ID: 9548444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
    Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
    J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
    Maloney MD; Lingwood CA
    J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation.
    Togayachi A; Kozono Y; Ikehara Y; Ito H; Suzuki N; Tsunoda Y; Abe S; Sato T; Nakamura K; Suzuki M; Goda HM; Ito M; Kudo T; Takahashi S; Narimatsu H
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11900-5. PubMed ID: 20547865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential change of carbohydrate antigen associated with differentiation of murine leukemia cells: i-I antigenic conversion and shifting of glycolipid synthesis.
    Kannagi R; Levery SB; Hakomori S
    Proc Natl Acad Sci U S A; 1983 May; 80(10):2844-8. PubMed ID: 6574453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line.
    Symington FW; Hedges DL; Hakomori S
    J Immunol; 1985 Apr; 134(4):2498-506. PubMed ID: 3855933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.
    Kannagi R; Stroup R; Cochran NA; Urdal DL; Young WW; Hakomori S
    Cancer Res; 1983 Oct; 43(10):4997-5005. PubMed ID: 6860431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glycosphingolipid composition of the human hepatoma cell line,Hep-G2.
    Spitalnik PF; Danley JM; Burger SR; Spitalnik SL
    Arch Biochem Biophys; 1989 Sep; 273(2):578-91. PubMed ID: 2549875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral glycosphingolipid expression in B-cell neoplasms.
    Kalisiak A; Minniti JG; Oosterwijk E; Old LJ; Scheinberg DA
    Int J Cancer; 1991 Dec; 49(6):837-45. PubMed ID: 1959988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.